Price $0.07 |
Market Cap
13.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.61
|
P/S
2.95
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-77.2K
|
FCF
-9.3
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-235.40%
|
ROI
-72.50%
|
|
ROA
-87.30%
|
EPS Growth
-16.70%
|
Current Ratio
2.1
|
Debt/Equity
76.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bimi International Medical Inc (BIMI) | $0.03 | - | - | 6.4M | Strong Buy |
| Evogene Ltd (EVGN) | $3.06 | - | - | 22.7M | Strong Buy |
| iCAD Inc (ICAD) | $1.51 | - | - | 38.2M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $11.55 | - | - | 78M | Strong Buy |
| Chromadex Corp (CDXC) | $3.26 | - | - | 105.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
